This audio is automatically created. Please let me know if there is feedback.
Diving Briefs:
- Flowers Foods places bread and raw sweeteners’ portfolios to withstand uncertainty of the use of GLP-1 drugs. The chief executive said to the analysts last week..
- Dave’s killer bread manufacturer recently pointed out the weaknesses of the bread space and is difficult to point to a particular cause Potential options are included Healthy eating habits, economic slowdown and GLP-1 drugs.
- Flowers CEO RYALS MCMULLIAN says consumers are moving to other categories such as traditional white and wheat bread, saying in a prepared statement related to the company’s four -quarter income. Differentiation and premium itemsGeorgia recently invested.
Dive Insights:
The bread and butter of flowers can be white bread, but the symbolic essential elements are a small part of the company’s future.
MCMULLIAN is a FlowerS moving the portfolio into a better food and holding a cleaner label, which is part of the effort to meet the needs of the consumer. This is a dave ‘killer brand, organic products without artificial materials or preservatives, and Grand CanyonFocus on gluten -free products.
Recently, Flower snack manufacturer with better snacks $ 795 Million. The purchase has diversified its portfolio by adding crackers, cookies, snacks, and baking mixes made of healthy and more recognized ingredients and adding the growth prospects for bread producers.
Simple factories, DAVE ‘S and Grand Canyon are one of those who can benefit if GLP-1 drugs are found to be long-term trends.
MCMULLIAN pointed out a study in which consumers using GLP-1 drugs were initially purchasing less food and more densely densely dense nutrient around the store. He pointed out that people who take GLP-1 drugs to lose weight ultimately reverse the course and spend more on center stores than before adoption.
Mcmullian said, “I don’t think anyone knows this or knows what long -term effects are. “The important thing to note is that the portfolio is successfully placed in every environment, regardless of the results.”
A study published in January was found GLP-1 Drug Food Expenditure Reduction. The purchase of processed items with calorie density, such as chips, baked products and cookies, was most influenced. About 14%of American adults have taken GLP-1 drugs to manage diseases such as weight loss or diabetes.
MCMULLIAN said that much pressure on bread focuses on sweet baked and traditional lumps such as white and wheat. At the same time, bread, rolls, breakfast and premium products were excellent.
Other brands of Flowers are Tastykake and MRS. It includes not only nature’s own and butter nut bread, such as Freshley ‘s, as well as indulgence snacks.
Mcmullian said, “We are aiming for innovation in more promising areas. “In the fourth quarter, the investment is being repaid due to the units and dollars that our major bread brands get or own.”
